한국어
English
日本語
中文(简体)
Zaronti Soft Capsule (Ethosuximide)
250mg
Soft capsule · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.
Ethosuximide is an antiepileptic ingredient used for the treatment of absence seizures.
MFDS ingredient code M223146
Ethosuximide is a drug in the antiepileptic class that acts on the nervous system. It is primarily used to control absence seizures in children and adults. It prevents seizures by suppressing abnormal electrical signals in the brain.
Ethosuximide reduces excessive electrical activity in nerve cells by blocking specific calcium channels within brain neurons. This inhibits the abnormal neural signaling that causes absence seizures. As a result, the frequency and intensity of seizures decrease.
Approved uses differ by product. Check each product's information for its actual use.
Ethosuximide specifically acts on absence seizures and, unlike other antiepileptic drugs, primarily targets T-type calcium channels. This makes it more effective for the treatment of absence seizures compared to other seizure types. Additionally, its side effect profile is relatively clear, making it widely used in treatment.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.